Preclinical experiments counsel that retatrutide could affect weight problems-linked most cancers development. In a very analyze led by Marathe et al., retatrutide-induced weightloss diminished tumor engraftment, delayed tumor onset, and significantly attenuated tumor development in pancreatic and lung most cancers designs, with bigger tumor suppre